Service
Personalized Gene-Editing Therapies
BIOTECHNOLOGY
byACGENETIC Therapeutics
United States (US)
ABOUT THE SERVICE
Development of individualized stem cell therapies utilizing gene-editing technologies to treat rare genetic diseases, initially focused on Limb-Girdle Muscular Dystrophy Type 2B/R2.
Information is owner-confirmed
Last updated 1 week ago
Price range